Cargando…
The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between Nov...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173107/ https://www.ncbi.nlm.nih.gov/pubmed/34093424 http://dx.doi.org/10.3389/fneur.2021.679430 |
_version_ | 1783702655510511616 |
---|---|
author | Xu, Jie Liu, Lingjuan Xiong, Jie Zhang, Lu Huang, Peng Tang, Li Xiao, Yangyang Li, Xingfang Li, Jian Luo, Yingying Li, Huiling Mao, Dingan Liu, Liqun |
author_facet | Xu, Jie Liu, Lingjuan Xiong, Jie Zhang, Lu Huang, Peng Tang, Li Xiao, Yangyang Li, Xingfang Li, Jian Luo, Yingying Li, Huiling Mao, Dingan Liu, Liqun |
author_sort | Xu, Jie |
collection | PubMed |
description | Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020. Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully. Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better. |
format | Online Article Text |
id | pubmed-8173107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81731072021-06-04 The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis Xu, Jie Liu, Lingjuan Xiong, Jie Zhang, Lu Huang, Peng Tang, Li Xiao, Yangyang Li, Xingfang Li, Jian Luo, Yingying Li, Huiling Mao, Dingan Liu, Liqun Front Neurol Neurology Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020. Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully. Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better. Frontiers Media S.A. 2021-05-20 /pmc/articles/PMC8173107/ /pubmed/34093424 http://dx.doi.org/10.3389/fneur.2021.679430 Text en Copyright © 2021 Xu, Liu, Xiong, Zhang, Huang, Tang, Xiao, Li, Li, Luo, Li, Mao and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Xu, Jie Liu, Lingjuan Xiong, Jie Zhang, Lu Huang, Peng Tang, Li Xiao, Yangyang Li, Xingfang Li, Jian Luo, Yingying Li, Huiling Mao, Dingan Liu, Liqun The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title | The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title_full | The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title_fullStr | The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title_full_unstemmed | The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title_short | The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis |
title_sort | clinical, radiologic, and prognostic differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173107/ https://www.ncbi.nlm.nih.gov/pubmed/34093424 http://dx.doi.org/10.3389/fneur.2021.679430 |
work_keys_str_mv | AT xujie theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT liulingjuan theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT xiongjie theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT zhanglu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT huangpeng theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT tangli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT xiaoyangyang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lixingfang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lijian theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT luoyingying theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lihuiling theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT maodingan theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT liuliqun theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT xujie clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT liulingjuan clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT xiongjie clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT zhanglu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT huangpeng clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT tangli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT xiaoyangyang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lixingfang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lijian clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT luoyingying clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT lihuiling clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT maodingan clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis AT liuliqun clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis |